189 related articles for article (PubMed ID: 35964686)
41. Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.
Casiraghi A; Longhena F; Faustini G; Ribaudo G; Suigo L; Camacho-Hernandez GA; Bono F; Brembati V; Newman AH; Gianoncelli A; Straniero V; Bellucci A; Valoti E
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015221
[TBL] [Abstract][Full Text] [Related]
42. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
[TBL] [Abstract][Full Text] [Related]
44. Coordination and redox properties of copper interaction with α-synuclein.
Valensin D; Dell'Acqua S; Kozlowski H; Casella L
J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
[TBL] [Abstract][Full Text] [Related]
45. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
46. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
[TBL] [Abstract][Full Text] [Related]
47. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
[TBL] [Abstract][Full Text] [Related]
48. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
[TBL] [Abstract][Full Text] [Related]
49. Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species.
Carta AR; Boi L; Pisanu A; Palmas MF; Carboni E; De Simone A
J Neurosci Methods; 2020 May; 338():108685. PubMed ID: 32173400
[TBL] [Abstract][Full Text] [Related]
50. Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.
Chen YH; Wu KJ; Hsieh W; Harvey BK; Hoffer BJ; Wang Y; Yu SJ
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205689
[TBL] [Abstract][Full Text] [Related]
51. Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease.
Cai W; Srivastava P; Feng D; Lin Y; Vanderburg CR; Xu Y; Mclean P; Frosch MP; Fisher DE; Schwarzschild MA; Chen X
Mol Neurodegener; 2022 Feb; 17(1):16. PubMed ID: 35197079
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.
Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S
Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358
[TBL] [Abstract][Full Text] [Related]
53. A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties.
Fassler M; Benaim C; George J
Cells; 2022 Nov; 11(23):. PubMed ID: 36497081
[TBL] [Abstract][Full Text] [Related]
54. The Prolyl Oligopeptidase Inhibitor KYP-2047 Is Cytoprotective and Anti-Inflammatory in Human Retinal Pigment Epithelial Cells with Defective Proteasomal Clearance.
Toppila M; Hytti M; Korhonen E; Ranta-Aho S; Harju N; Forsberg MM; Kaarniranta K; Jalkanen A; Kauppinen A
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37372009
[TBL] [Abstract][Full Text] [Related]
55. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
56. Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α-synuclein Parkinson's disease rat model.
Musacchio T; Rebenstorff M; Fluri F; Brotchie JM; Volkmann J; Koprich JB; Ip CW
Ann Neurol; 2017 Jun; 81(6):825-836. PubMed ID: 28470693
[TBL] [Abstract][Full Text] [Related]
57. α-Synuclein and neuronal cell death.
Yasuda T; Nakata Y; Mochizuki H
Mol Neurobiol; 2013 Apr; 47(2):466-83. PubMed ID: 22936307
[TBL] [Abstract][Full Text] [Related]
58. Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
Chiu YS; Wu KJ; Yu SJ; Wu KL; Wang YS; Lin J; Chu CY; Chen S; Chen H; Hsu SC; Wang Y; Chen YH
PLoS One; 2023; 18(9):e0291927. PubMed ID: 37733672
[TBL] [Abstract][Full Text] [Related]
59. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
60. Neuropathology of α-synuclein in Parkinson's disease.
Choong CJ; Mochizuki H
Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
